Sign Out
Each single use vial contains: 3.5 mg of bortezomib as a sterile lyophilized powder.
The 10 mL vial contains 38.5 mg powder for solution for injection for the 3.5 mg product.
VELCADE 3.5 mg for injection (sterile lyophilized powder) is an antineoplastic agent available for intravenous injection (IV) or subcutaneous (SC) use.
Excipients/Inactive Ingredients: 35 mg mannitol, USP/EP (IV or SC use (E421).
